Compass Therapeutics announces annual shareholder meeting webcast
PUBT · 3h ago
Share
Listen to the news
- Compass Therapeutics set its annual shareholder meeting for June 10, 2026 in virtual format.
- Shareholders will vote to elect two Class III directors to serve until 2029.
- Ballot includes ratification of CohnReznick as independent registered public accounting firm for fiscal 2026.
- Advisory votes will cover named executive officer pay.
- Separate advisory vote will set preferred frequency for future say-on-pay votes.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Compass Therapeutics Inc. published the original content used to generate this news brief on April 27, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved